SEARCH LISTED COMPANY
ANY AUS OR NZ COMPANY
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
Level 5, 126 Philip Street Sydney NSW 2000 GPO Box 5193 Sydney NSW 2001
Tel : 1300 288 664 or +61 2 9698 5414The suspension of trading in the securities of LTR Pharma Limited will be lifted immediately following the release by LTP of an announcement regarding the results of primary and secondary clinical study results. | 07/06/2024 |
Initial results show SPONTAN achieves rapid absorption and faster onset of action compared to oral PDE5 inhibitors (i.e., vardenafil, sildenafil, tadalafil). SPONTAN's nasal spray technology delivered a similar amount of drug (Cmax) at half the dose of the oral PDE5 and was significantly faster. Better safety profile for SPONTAN compared to oral PDE5 dosing. Positive data results will be used for regulatory filings in key markets. Critical Company milestone showing that SPONTAN could disrupt the global PDE5 market. | 07/06/2024 |
The securities of LTR Pharma Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of LTP, pending the release of an announcement regarding the results of a primary and secondary clinical study | 06/06/2024 |
listed entity carried for record purposes only | 11/12/2023 |
NAME | TITLE | DATE OF APPT |
---|---|---|
Lee Rodne | Executive Chairman | 11/12/2023 |
Julian Chick | Independent Director | 11/12/2023 |
Maja McGuire | Independent Director | 11/12/2023 |
David Hwang | Company Secretary | 01/04/2025 |
Elizabeth Spooner | Company Secretary | 01/04/2025 |
Date of first appointment, title may have changed.
NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
---|
Date of first appointment, title may have changed.